John Hamer, Ph.D.
John is a Managing Partner at DCVC Bio. Prior to joining DCVC, John was a VP at Monsanto and Managing Director of Monsanto Growth Ventures (MGV). Before joining MGV, John was a Managing Director at Burrill & Company. Prior to his career in venture capital, John was an entrepreneur, initially at Paradigm Genetics, where he joined as a visiting scientist before becoming Chief Science Officer and eventually President and CEO following the company’s IPO. After Paradigm, John founded and served as CEO of Arête Therapeutics, which earned backing from leading life science venture firms.
John started his career in academia, rising to the rank of Full Professor in the Department of Biological Sciences at Purdue University, where he was a David and Lucille Packard Fellow and an NSF Presidential Faculty Fellow. John received a B.Sc. and an M.Sc. from the University of Windsor and a Ph.D. in Microbiology from the University of California, Davis.